EE38 A Review of Cost Effectiveness Analysis (CEA) of Immuno-Oncologic Therapies for Squamous Cell Carcinoma Head and Neck Cancer (SCCHN): Lessons Learned
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.290
https://www.valueinhealthjournal.com/article/S1098-3015(22)00491-0/fulltext
Title :
EE38 A Review of Cost Effectiveness Analysis (CEA) of Immuno-Oncologic Therapies for Squamous Cell Carcinoma Head and Neck Cancer (SCCHN): Lessons Learned
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00491-0&doi=10.1016/j.jval.2022.04.290
First page :
Section Title :
Open access? :
No
Section Order :
10256